Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Degradable implantable medical devices

a medical device and implantable technology, applied in the field of medical devices and methods, can solve the problems of reocclusion of the treated lesion, thrombosis or other adverse medical effects, affecting the treatment effect, and increasing the amount of intimal hyperplasia, etc., and achieve the effect of reducing the rate of the implantable structur

Inactive Publication Date: 2006-10-12
ELIXIR MEDICAL CORP
View PDF42 Cites 372 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0022] In a fourth aspect of the present invention, the degradation rate of the implantable structure is controlled at least in part by the manipulation of corrosion enhancing and / or corrosion resisting elements in the implant structure. Thus, atoms or compounds which lower the resistance of a metal or metal alloy to corrosion can be added to or increased if already present in these materials. Likewise, one or more corrosion resisting elements may be depleted. Such manipulation of elements may occur on a surface of the implant structure, throughout the implant structure or adjacent to a grain boundary of a metal or alloy to control corrosion of the metal or alloy.
[0026] In an eighth aspect of the invention, the degradation rate of the implantable structure is controlled at least in part by incorporating or manipulating a protective layer. In some embodiments, the implantable structure comprises an implantable body comprising a metal, metal alloy or combination thereof having a degradation rate, and a layer which covers at least a portion of the implantable body, wherein aspects of the layer are controlled which controls the degradation rate of the implantable body. The protective layer may comprise a passivation layer or a coating. Such coatings may comprise a polymer, metal, metal alloy, therapeutic agent, corrosive agent, radiopaque agent or combination of these. Such aspects of the protective layer may include thickness, chemical composition, chemical permeability, durability, amount of coverage of the implantable structure, or a combination of thereof, such aspects of the protective layer may include amount of corrosion-resistant oxides. Optionally, the protective layer may have openings which reveal underlying portions of the implantable body, wherein the openings assist in controlling the degradation rate of the implantable body.

Problems solved by technology

However, as the disease progresses, its symptoms become more apparent, despite drug therapy.
However, restenosis, or reocclusion of the treated lesion, has plagued PTCA.
Such permanent implantation may increase the amount of intimal hyperplasia, thrombosis or other adverse medical effects.
Thus, these stents do not permit temporary placement within the body unless patient and surgeon are prepared to undertake a second procedure to remove the stent, which is difficult or impossible in most cases.
Further, the presence of a stent which remains mechanically rigid could potentially cause complications to the patient.
Such polymer stents, however, tend to provide less mechanical support for the vessel wall and therefore have to be substantially thicker than a comparable metallic stent.
The thickness can reduce the available blood flow lumen and can cause undesirable biologic responses.
Such degradable metal stents, however, often compromise strength, profile, and other desirable characteristics which are found in conventional metal stents.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Degradable implantable medical devices
  • Degradable implantable medical devices
  • Degradable implantable medical devices

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0134] A 1.52 mm diameter hole is drilled in the center of a 5 mm diameter cobalt rod by EDM drill or Swiss screw. The rod is then centerless grind to 1.63 mm outer diameter. The resulting cobalt tube is annealed at 850 degrees C. for 1 hr in a vacuum oven. The tube is laser cut into an 18 mm long coronary stent. After the slag and scale are removed by chemical treatment, the stent is placed on a 0.020″ diameter metal mandrel and rotated. The air nozzle of a sandblaster (Econoline of Grand Haven, Mich.) with 360 mesh aluminum oxide abrasive blasting media is directed at the stent and air activated for 10 seconds to create a textured surface on all surfaces of the cobalt stent. The stent is cleaned by dipping in hot water beakers several times followed by dipping in 100% isopropanol beaker. The stent is then placed inside a beaker filled with 100% isopropanol. This beaker is placed in an ultrasonic bath (Branson Ultrasonic Corporation of Danbury Conn.) and the stent is cleaned for 5 ...

example 2

[0136] Before crimping onto a delivery catheter, the coronary stent made in Example 1 is coated with a matrix comprising of 33% Rapamycin and 66% Polyethylene-vinyl alcohol copolymer. After drying, the stent is crimped onto the balloon of a stent delivery catheter. The stent delivery system is sealed inside a pouch and sterilized by EtO.

[0137] The stent delivery system is inserted over a guidewire until the stent is within a lesion in the left circumflex artery. The stent is deployed onto the lesion and the cobalt metal starts to dissolve its mass over a period of time while the drug is released.

example 3

[0138] A coronary stent is made from 1.6 mm OD and 0.6 mm ID tungsten rod. The hole is enlarged to 1 mm by an EDM drill. The rod is then centerless grind to 1.11 mm outer diameter. The resulting tungsten tube is annealed at 1400 degrees C. in a vacuum oven for 1 hour. Slots are cut into the tube with a stamp EDM such that a 25 mm long stent pattern is formed. The non EDM ends are removed. After the slag and scale are removed by chemical treatment, the stent is etched for 6 hours in 45 degree Celsius heated 2N Hydrochloric Acid to induce corrosive pit features on its surface.

[0139] The stent is cleaned by dipping in hot water beakers several times followed by dipping in 100% ethanol beaker. The stent is then placed inside a beaker filled with 100% ethanol. This beaker is placed in an ultrasonic bath (Branson Ultrasonic Corporation of Danbury Conn.) and the stent is cleaned for 5 minutes in the bath. After drying, the stent is crimped onto the balloon of a 3.5×27 mm stent delivery ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
surface roughnessaaaaaaaaaa
surface roughnessaaaaaaaaaa
surface roughnessaaaaaaaaaa
Login to View More

Abstract

Devices and methods are provided for an implantable medical device which is degradable over a clinically relevant period of time. The medical devices may have the form of implants, graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants including bone plates, bone screws, dental implants, spinal disks, or the like. In preferred embodiments, the implantable medical device comprises an implantable luminal prosthesis, such as vascular and non-vascular stents and stents grafts.

Description

CROSS-REFERENCES TO RELATED APPLICATIONS [0001] This application claims priority to U.S. Provisional Patent Application No. 60 / 668,707 (Attorney Docket No. 022265-000200US), filed on Apr. 5, 2005, incorporated herein by reference for all purposes.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] The present invention relates to medical devices and methods. More particularly, the present invention relates to implantable luminal prostheses and other medical devices which degrade in a body environment. [0004] 2. Description of the Background Art [0005] Coronary artery disease is the leading cause of death in the industrialized countries around the world. It begins as the accumulation of atherosclerotic deposits in the walls of the major arteries which supply blood to the heart. As the deposits accumulate, normal blood flow to the heart is restricted. The heart has several compensatory mechanisms, which, to a point, can offset such diminished blood flow. Beyond these c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F2/06A61F2/82
CPCA61F2/02A61F2/06A61F2/07A61F2/82A61F2220/0058A61F2250/003A61F2250/0067A61F2/90A61F2210/0004B23K26/0006B23K26/40B23K26/0624B23K26/382B23K26/355B23K2101/06B23K2103/02B23K2103/12B23K2103/50
Inventor YAN, JOHNSIRHAN, MOTASIMCRYER, BRETTBHAT, VINAYAK D.
Owner ELIXIR MEDICAL CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products